IIOL Executive Director Tina Woods explains why

First patient dosed in Phase 1 trial testing epi

Rokit Healthcare said it appointed Nadan Lee as c

MitoRx presented preclinical results for its lead

Largest-ever analysis of knee osteoarthritis cha

$15 million funding signals growing demand for p

With their healthspan eroding in real time, Vall

New clinical intelligence system aims to help ph

Muna Therapeutics announced on 4 June 2026 that a

Celularity and Fountain Life announced that Cenpl

Hengrui Pharma and Kailera Therapeutics presented

OrsoBio will present clinical and preclinical dat

Antag Therapeutics presented Phase 1 and preclini

New human data suggest the stress hormone may be

Eos SENOLYTIX says new preclinical findings hig

Deep Science Ventures Harry Macpherson explains

South Korea has become the first country to fold

FibroBiologics has enrolled and dosed the first p

Alnylam and Inceptive announced a strategic colla

Fractyl Health reported one-year open-label REVEA

Longeveron will participate in the BIO Internatio

Leica Biosystems, a Danaher company, announced on

Biomarker testing, AI-powered health insights an

NUS launches world’s first postgraduate progra

New funding from The Michael J Fox Foundation ba

PMDA signals support for the regulatory submissi

Cortechs.

Winona has launched the Winona Research Initiativ

Fresenius Medical Care launched Kinexus Worldwide

Niagen Bioscience announced that the ChromaDex Ex

BrainStorm Cell Therapeutics Inc.

Cambrian Bio will present two posters on ATX-304

The longevity biotech is accelerating toward the

Biomarker intelligence company launches Terra pl

Deep Science Ventures and Medicines Discovery Ca

Clinic taps growing demand for personalized heal

New $400 million initiative will combine human b

C2N Diagnostics has formed a collaboration with S

Voyager Therapeutics announced FDA clearance of i

Eccogene and AstraZeneca will present multiple cl

Augustine Therapeutics will present a late-breaki

Corsair Pharma completed a first-in-human phase 1

NanoDetection Technology and Oligomerix have exec

HeartSciences launched MyoVista Insights version

Australian regulators clear Scribe Therapeutics

Muse cells show promise across a range of early

TimePie’s 7th longevity forum will bring toget

The company’s gene therapy candidate aims to s

HAYA Therapeutics announced that the first cohort

CellProthera is advancing its CD34+ stem cell the